These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33252492)

  • 1. Maintenance of statin therapy among people living with HIV.
    Boettiger DC; Kerr S; Chattranukulchai P; Siwamogsatham S; Avihingsanon A
    AIDS; 2021 Mar; 35(4):567-574. PubMed ID: 33252492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis.
    Boettiger DC; Newall AT; Chattranukulchai P; Chaiwarith R; Khusuwan S; Avihingsanon A; Phillips A; Bendavid E; Law MG; Kahn JG; Ross J; Bautista-Arredondo S; Kiertiburanakul S
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25494. PubMed ID: 32562359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
    Boettiger DC; Chattranukulchai P; Avihingsanon A; Chaiwarith R; Khusuwan S; Law MG; Ross J; Kiertiburanakul S
    PLoS One; 2021; 16(9):e0256926. PubMed ID: 34499685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.
    Boccara F; Kumar PN; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS;
    J Am Coll Cardiol; 2020 May; 75(20):2570-2584. PubMed ID: 32234462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.
    Burkholder GA; Muntner P; Zhao H; Mugavero MJ; Overton ET; Kilgore M; Drozd DR; Crane HM; Moore RD; Mathews WC; Geng E; Boswell S; Floris-Moore M; Rosenson RS
    J Clin Lipidol; 2018; 12(4):988-998.e5. PubMed ID: 29853312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Tanner RM; Colantonio LD; Kilgore ML; Mefford MT; Chachappan DT; Mues KE; Safford MM; Rosenson RS; Muntner P
    J Clin Lipidol; 2020; 14(5):720-729. PubMed ID: 32680814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin gap in patients living with HIV: assessing dose appropriateness.
    Pincus KJ; Blackman AL; Suen SY; Devabhakthuni S; Gale S; Noel ZR; Seung H; Pandit NS
    HIV Med; 2021 Nov; 22(10):917-923. PubMed ID: 34369052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients.
    Blackman AL; Pandit NS; Pincus KJ
    HIV Med; 2020 Mar; 21(3):135-141. PubMed ID: 31876122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV--Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015.
    Rosenson RS; Colantonio LD; Burkholder GA; Chen L; Muntner P
    J Am Heart Assoc; 2018 Dec; 7(24):e010345. PubMed ID: 30526249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors That Affect Quality of Life among People Living with HIV Attending an Urban Clinic in Uganda: A Cohort Study.
    Mutabazi-Mwesigire D; Katamba A; Martin F; Seeley J; Wu AW
    PLoS One; 2015; 10(6):e0126810. PubMed ID: 26039733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications.
    Wiggins BS; Lamprecht DG; Page RL; Saseen JJ
    Am J Cardiovasc Drugs; 2017 Oct; 17(5):375-389. PubMed ID: 28364370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease.
    Gallegos Aragon K; Ray G; Conklin J; Stever E; Marquez C; Magallanes A; Anderson J; Jakeman B
    Am J Health Syst Pharm; 2022 Nov; 79(22):2026-2031. PubMed ID: 35976174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
    Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.
    Eckard AR; Jiang Y; Debanne SM; Funderburg NT; McComsey GA
    J Infect Dis; 2014 Apr; 209(8):1156-64. PubMed ID: 24415784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002-2016.
    Romanelli RJ; Ito MK; Karalis DG; Huang HC; Iorga ŞR; Kam IW; Thompson S; Azar KMJ
    J Clin Lipidol; 2020; 14(3):305-314. PubMed ID: 32362513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics.
    Boccara F; Kumar P; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS
    Am Heart J; 2020 Feb; 220():203-212. PubMed ID: 31841795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.